Psychiatry

A review of suicide prediction models reveals limited practical application on larger populations.

Despite previous observations that high-quality diet correlates to lower depression symptoms, new results paint a different picture.

In a rare clinical trial, stem cell transplantation appeared to provide greater protection against MS progression than DMT.

If approved by the FDA later this year, the Allergan drug would become the first oral CGRP receptor antagonist approved for acute migraine treatment.

One of the pioneer investigators of ketamine for depression explains what its recent approval for a severe form of the condition means for patients running out of options.

The therapy becomes the first novel mechanism of action-driven drug approved for depression in 30 years.

The prevalence of anxiety, depression, and ADD was higher in patients with this excessive sweating disorder than the general population.

The CNS stimulant was approved as an extended-released capsule intended to serve as a first-line ADHD therapy.

A large retrospective study of patients with acne found no significant association between isotretinoin exposure and depression.

Investigators found that the prevalence of asthma in patients with opioid dependence was more than double the national prevalence.

Anxiety and depression each contribute to impaired cognition in patients with MS and other immune-mediated disorders, a new study shows.

Ketamine looks promising as a potential therapy for treatment-resistant depression. The problem is that more research is needed to understand it.

A study of medical school applicants through their education showed those more expected to become a doctor by their parents are more likely to feel the strains of becoming one.

If approved, Spravato would become the first novel mechanism of action in 30 years to treat major depressive disorder.

The US Preventive Services Task Force has recommended that clinicians refer pregnant and postpartum persons who are at risk of depression for counseling services.

Physicians on the front lines of care should be empowered to consider alternative treatment options for patients in significant need.

Teenaged athletes to suffer from sports-related concussion symptoms may fare better from more active exercise, despite standard concussion treatment strategies.

A new study found that physician mothers commonly have responsibilities outside of their children and patients—and that such burdens are linked to more anxiety and burnout.

A new cohort analysis shows patients switching or adding on the antipsychotic drug are not at a worse risk of suicide or other adverse events.

A new study found the biggest burden of benzodiazepine-related visits have come from primary care physicians, and that efforts to limit sedative prescription may have to start there.

Why certain age-related factors particularly impact the mental health of women at the age their menopause symptoms appear.

The antipsyhoctic could receive a new indication in 2019, and though the field of bipolar disorder care is far from perfect, it should improve with this addition.

Differing therapies, inaccurate regimens, missed diagnoses—issues can compound quickly for patients with PD seeking care for something else.

Some of the most common symptoms of COPD drive anxiety in its patients. An England-based study sought out a cost-effective response.

A pilot study testing a multi-tasking game in children with autism and ADHD demonstrated feasibility, acceptability, and non-significant efficacy.